These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 5428170)

  • 21. [Clinical effects of L-dopa in Parkinson's disease].
    Fasano VA
    Sist Nerv; 1970; 22(2):119-23. PubMed ID: 5504550
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effects of L-dopa or amantadine treatment on the spindles of sleep in Parkinson's syndromes].
    Puca FM; Bricolo A; Turella G
    Rev Neurol (Paris); 1972 Aug; 127(2):313. PubMed ID: 4666639
    [No Abstract]   [Full Text] [Related]  

  • 23. [Evaluation of 12 months treatment with L-DOPA of patients with Parkinson's disease].
    van der Drift JH
    Ned Tijdschr Geneeskd; 1972 Nov; 116(48):2185-93. PubMed ID: 4639073
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effectiveness of a combination therapy in the Parkinson syndrome by amantadine hydrochloride and anticholinergic agents].
    Gospavić J; Vidaković Z
    Srp Arh Celok Lek; 1974 Jun; 102(6):447-57. PubMed ID: 4450143
    [No Abstract]   [Full Text] [Related]  

  • 25. [Conservative therapy in the Parkinson syndrome].
    Birkmayer W
    Wien Med Wochenschr; 1971 Nov; 121(46):827-9. PubMed ID: 5138823
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined treatment of Parkinson's disease with amantadine and L-dopa.
    Scotti G
    Lancet; 1970 Jun; 1(7661):1394-5. PubMed ID: 4194144
    [No Abstract]   [Full Text] [Related]  

  • 27. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
    Reveno WS; Bauer RB; Rosenbaum H
    Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462
    [No Abstract]   [Full Text] [Related]  

  • 28. [On the treatment of Parkinson's disease with intravenous administration of amantadine (77 cases)].
    Fasano VA; Urciuoli R; Broggi G
    Minerva Med; 1971 Oct; 62(82):3968-70. PubMed ID: 5125055
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effects of additional medication of Amantadine sulfate in L-dopa-pretreated patients with Parkinson's syndrome (author's transl)].
    Schneider E; Fischer PA; Jacobi P
    Med Klin; 1974 Mar; 69(13):541-5. PubMed ID: 4831456
    [No Abstract]   [Full Text] [Related]  

  • 30. [Combination of amantadine and levodopa in the treatment of Parkinson's disease. Indications. Results. Study of 58 cases].
    Sigwald J; Raymondeaud C
    Nouv Presse Med; 1972 Apr; 1(18):1237-9. PubMed ID: 5025538
    [No Abstract]   [Full Text] [Related]  

  • 31. [The treatment of parkinsonism with amantadine].
    Völler GW
    Dtsch Med Wochenschr; 1970 Apr; 95(17):934-7. PubMed ID: 5439551
    [No Abstract]   [Full Text] [Related]  

  • 32. Blink reflex studies in patients with Parkinsonism before and during therapy.
    Penders CA; Delwaide PJ
    J Neurol Neurosurg Psychiatry; 1971 Dec; 34(6):674-8. PubMed ID: 5158781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Drug therapy of Parkinson's disease with amantadine and levodopa].
    Fieschi C; Nardini M; Casacchia M; Reitano M; Tedone ME; Ferrari P; Robotti E
    Sist Nerv; 1970; 22(2):126-43. PubMed ID: 5504552
    [No Abstract]   [Full Text] [Related]  

  • 34. [Current therapeutic problems of the parkinson syndrome].
    Völler GW; Kapp W
    Med Welt; 1971 Aug; 33():1280-2. PubMed ID: 5566844
    [No Abstract]   [Full Text] [Related]  

  • 35. [Levo-dopa in the treatment of Parkinson's disease].
    Fasano VA; Urciuoli R; Broggi G; Cannella M
    Minerva Med; 1969 Nov; 60(95):4733-45. PubMed ID: 5357313
    [No Abstract]   [Full Text] [Related]  

  • 36. [Intravenous and oral treatment with amantadine sulfate in Parkinson disease].
    Brenner M; Haass A; Jacobi P; Schimrigk K
    Nervenarzt; 1988 Mar; 59(3):180-4. PubMed ID: 3374720
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Amantadine in Parkinson's disease].
    Vecchi L
    Clin Ter; 1971 Jun; 57(5):471-5. PubMed ID: 5113576
    [No Abstract]   [Full Text] [Related]  

  • 38. Preliminary observations on L-dopa in the treatment of Parkinson's disease.
    Jelsma F; Roth R; Ross P; Davis J
    J Ky Med Assoc; 1971 Apr; 69(4):265-9. PubMed ID: 5577419
    [No Abstract]   [Full Text] [Related]  

  • 39. [Preliminary observations on the use of L-DOPA in the treatment of the akinetic symptoms of Parkinson's disease].
    Uriciuoli R; Nivoli GC
    Minerva Med; 1968 May; 59(43):2516-21. PubMed ID: 5664430
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapeutic association of amantadine and L-Dopa in parkinsonism].
    Signorelli CD; D'Andrea F; De Divitiis E; Cerillo A
    Minerva Med; 1971 Oct; 62(82):4015-6. PubMed ID: 5125068
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.